- Home
- SYRE vs HGTY Comparison
SYRE vs HGTY Comparison
Compare SYRE & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- HGTY
- Stock Information
- Founded
- SYRE 2013
- HGTY 1984
- Country
- SYRE United States
- HGTY United States
- Employees
- SYRE N/A
- HGTY N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- HGTY Specialty Insurers
- Sector
- SYRE Health Care
- HGTY Finance
- Exchange
- SYRE Nasdaq
- HGTY Nasdaq
- Market Cap
- SYRE 1.1B
- HGTY 1.1B
- IPO Year
- SYRE 2016
- HGTY N/A
- Fundamental
- Price
- SYRE $23.56
- HGTY $11.11
- Analyst Decision
- SYRE Strong Buy
- HGTY Hold
- Analyst Count
- SYRE 6
- HGTY 7
- Target Price
- SYRE $57.60
- HGTY $13.67
- AVG Volume (30 Days)
- SYRE 1.3M
- HGTY 109.6K
- Earning Date
- SYRE 11-06-2025
- HGTY 11-04-2025
- Dividend Yield
- SYRE N/A
- HGTY N/A
- EPS Growth
- SYRE N/A
- HGTY 90.09
- EPS
- SYRE N/A
- HGTY 0.20
- Revenue
- SYRE N/A
- HGTY $1,303,397,000.00
- Revenue This Year
- SYRE N/A
- HGTY $15.91
- Revenue Next Year
- SYRE N/A
- HGTY N/A
- P/E Ratio
- SYRE N/A
- HGTY $54.43
- Revenue Growth
- SYRE N/A
- HGTY 17.90
- 52 Week Low
- SYRE $10.91
- HGTY $8.03
- 52 Week High
- SYRE $40.26
- HGTY $13.32
- Technical
- Relative Strength Index (RSI)
- SYRE 70.08
- HGTY 37.09
- Support Level
- SYRE $21.88
- HGTY $11.04
- Resistance Level
- SYRE $24.02
- HGTY $11.35
- Average True Range (ATR)
- SYRE 1.62
- HGTY 0.36
- MACD
- SYRE 0.32
- HGTY -0.11
- Stochastic Oscillator
- SYRE 93.11
- HGTY 3.46
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.